Mode
Text Size
Log in / Sign up

Meta-analysis on psychological interventions and early psychosis care for depression and psychosis

Meta-analysis on psychological interventions and early psychosis care for depression and psychosis
Photo by Brett Jordan / Unsplash
Key Takeaway
Consider staged care models and C-reactive protein monitoring for depression and psychosis, noting evidence gaps and speculative protocols.

This is a meta-analysis synthesizing evidence on psychological interventions for subclinical symptoms and early intervention for first-episode psychosis. The authors report that psychological interventions at subclinical symptom levels reduce major depression incidence by 43% at post-treatment and 33% at 12-month follow-up, based on 30 trials with N = 7,201. They also find that shorter duration of untreated illness is associated with a 70% greater likelihood of treatment response, and that early intervention for first-episode psychosis reduces hospitalisation by 26%.

The authors present a speculative multi-domain monitoring protocol and identify prospective multi-domain monitoring trials as an urgent research priority. They note that clinical staging models adapted from oncology provide a graduated diagnostic architecture for condition-based care, with inflammatory monitoring via C-reactive protein being most implementation-ready.

Limitations include the speculative nature of the proposed protocol and the need for more prospective trials. The evidence is synthesized from meta-analytic sources, and associations are reported rather than causal relationships. Practice relevance is restrained, focusing on staged care models and ready implementation of C-reactive protein monitoring.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Mental disorders are the leading cause of years lived with disability worldwide, yet the dominant clinical model remains reactive, intervening only after diagnostic thresholds are met. Drawing on the engineering distinction between run-to-failure and condition-based maintenance, this review argues that psychiatry faces a quantifiable intervention threshold gap. Synthesising recent meta-analytic evidence, we show that psychological interventions at subclinical symptom levels reduce major depression incidence by 43% at post-treatment and 33% at 12-month follow-up (individual-participant-data meta-analysis; 30 trials; N = 7,201), that shorter duration of untreated illness is associated with 70% greater likelihood of treatment response, and that early intervention for first-episode psychosis reduces hospitalisation by 26%. We review convergent evidence across five modifiable domains — sleep and glymphatic clearance, nutritional psychiatry, allostatic load regulation, autonomic function, and psychoneuroimmunological monitoring — selected for objective measurability, meta-analytic interventional support, identified mechanistic pathways, and population-level scalability. These domains form a mechanistically interconnected network in which deterioration in one can cascade across others. Clinical staging models, adapted from oncology, provide the graduated diagnostic architecture for condition-based care. We present a speculative multi-domain monitoring protocol with parameters, frequencies, and action thresholds calibrated to clinical stage. Among the five domains, inflammatory monitoring via C-reactive protein emerges as the most implementation-ready, with established clinical thresholds, demonstrated treatment-selection utility, and symptom-specific associations with neurovegetative features consistent with an immuno-metabolic depression subtype. Prospective multi-domain monitoring trials are identified as the most urgent research priority.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.